Skip to main content

Eversept Partners, LP

Position in ESPR — Esperion Therapeutics, Inc.

CIK 1697013 NEW YORK, NY

Position in ESPR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
1,735,963
-54.9% QoQ
Ownership
0.674%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ESPR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Eversept Partners, LP holds $209,186,993 across 4 Drug Manufacturers - Specialty & Generic names.

# Ticker Company Shares Value (USD) Open

All Filings in ESPR

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-03-31 1,735,963
2025-12-31 3,851,133